International COVID-19 biomarkers colloquium

Richard C Becker¹, Diana A Gorog^{2

3

4}

Affiliations

¹ University of Cincinnati College of Medicine, Cincinnati, OH, USA. BECKERRC@ucmail.uc.edu.
² National Heart and Lung Institute, Imperial College, London, UK.
³ East and North Hertfordshire NHS Trust, Stevenage, Hertfordshire, UK.
⁴ School of Life and Medical Sciences, Postgraduate Medical School, University of Hertfordshire, Hatfield, UK.

Editorial

Richard C Becker et al. J Thromb Thrombolysis. 2021 Nov.

. 2021 Nov;52(4):983-984.

doi: 10.1007/s11239-021-02601-5. Epub 2021 Nov 4.

Richard C Becker¹, Diana A Gorog^{2

3

4}

¹ University of Cincinnati College of Medicine, Cincinnati, OH, USA. BECKERRC@ucmail.uc.edu.
² National Heart and Lung Institute, Imperial College, London, UK.
³ East and North Hertfordshire NHS Trust, Stevenage, Hertfordshire, UK.
⁴ School of Life and Medical Sciences, Postgraduate Medical School, University of Hertfordshire, Hatfield, UK.

No abstract available

Figures

1. Ali M, Girgis S, Hassan A, Rudick S, Becker RC. Inflammation and coronary artery disease: from pathophysiology to canakinumab anti-inflammatory thrombosis outcomes study (CANTOS) Coron Artery Dis. 2018;29:429–437. doi: 10.1097/MCA.0000000000000625. - DOI - PubMed
1. Becker RC. Emerging paradigms, platforms, and unifying themes in biomarker science. J Am Coll Cardiol. 2007;50:1777–1780. doi: 10.1016/j.jacc.2007.07.039. - DOI - PubMed